Search
| (ENZN) NASDAQ | |||
| Last Trade | 9.85 | ||
| Change(%) | ![]() | +0.04 | |
| Volume | 652143 | ||
| 7:47 PM - Mar 09, 2010 | |||
News
Enzon to Present at NewsMakers in the Biotech Industry Conference
Enzon to Release Second Quarter 2009 Earnings on Tuesday, August 4, 2009; Conference Call and Webcast to Follow
Enzon to Present at BMO Focus on Healthcare Conference
Enzon Enhances Governance with the Addition of a New Non-Executive Chairman and New Independent Director

Enzon to Release First Quarter 2009 Earnings on Thursday, May 7, 2009; Conference Call and Webcast to Follow
Enzon Discontinues its Plan to Spin-off its Biotechnology Business
Enzon Reports Solid Second Quarter 2008 Results
-- Product revenues increase 17% --
Enzon Files For Spin-Off of Biotech Business

UCB"s Cimzia® Approved in the U.S. for Adult Patients Suffering from Moderate to Severe Rheumatoid Arthritis
-- Enzon to receive royalties for PEGylation technology--
Enzon Treats Patients with Survivin Antagonist
-- Enzon's compound advances into the clinic for patients with solid tumors and lymphomas--
Enzon to Present at 29th Annual Cowen and Company Conference
Enzon to Present at 11th Annual BIO CEO & Investor Conference
